Special Issue "Non-Psychotropic Phytocannabinoids: A New Source of Drugs"
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 9374
Interests: secondary metabolites; ethnopharmacology; abiotic stress; abiotic stress tolerance; cannabis sativa; cannabaceae; medical marijuana; phytocannabinoids; CB1 receptor; cannabidiol; tetrahydrocannabinol; CB2 receptor; cannabinoids; cannabinoid receptor agonists; cannabinoid receptor antagonists; cannabinoid receptor modulators
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Botany, Phytochemistry and Biological Activities of the Plant Natural Products
Special Issue in International Journal of Molecular Sciences: New Strategies for Drought Tolerance of Crops: Physiological, Biochemical, and Molecular Aspects
Special Issue in Pharmaceuticals: Therapeutic Potential for Cannabinoids and Their Receptors
Special Issue in Biology: Biological Bases of Alzheimer's Disease
Special Issue in Plants: Integrative Genomics and System Biology in Field Crops
One of the most controversial and debated plants in history is Cannabis sativa. Human societies have considered C. sativa as a food, a medicine, and for religious purposes. All the virtues of C. sativa are due to the multitude of its chemical components, such as phytocannabinoids, terpenoids, flavonoids, and alkaloids, that have been extracted, purified, and tested in various preclinical models. Trans-Δ-9-tetrahydrocannabinol (D9-THC) is the phytocannabinoid responsible for the psychotropic effects of C. sativa, but in recent years, in many parts of the world, C. sativa cultivars called "light", which contain low levels of D9-THC and high levels of non-psychotropic phytocannabinoids such as cannabidiol (CBD), have been cultivated. This Special Issue will collect manuscripts on the biosynthetic, extractive, and analytical aspects of phytocannabinoids without psychotropic activity. Furthermore, particular interest will be given to the potential therapeutic applications of new characterized phytocannabinoids.
Dr. Andrea Mastinu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Cannabis sativa
- Medicinal chemistry
- Organic chemistry
- Analitycal chemistry
- Endocannabinoid system